Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

The Interplay between Immune System and Microbiota in Diabetes.

Moffa S, Mezza T, Cefalo CMA, Cinti F, Impronta F, Sorice GP, Santoro A, Di Giuseppe G, Pontecorvi A, Giaccari A.

Mediators Inflamm. 2019 Dec 30;2019:9367404. doi: 10.1155/2019/9367404. eCollection 2019. Review.

2.

Bile Modulates Secretion of Incretins and Insulin: A Study of Human Extrahepatic Cholestasis.

Mezza T, Moffa S, Ferraro PM, Quero G, Capece U, Carfì A, Cefalo CMA, Cinti F, Sorice GP, Impronta F, Mari A, Pontecorvi A, Alfieri S, Holst JJ, Giaccari A.

J Clin Endocrinol Metab. 2019 Jul 1;104(7):2685-2694. doi: 10.1210/jc.2018-02804.

PMID:
30874733
3.

Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives.

Cefalo CMA, Cinti F, Moffa S, Impronta F, Sorice GP, Mezza T, Pontecorvi A, Giaccari A.

Cardiovasc Diabetol. 2019 Feb 28;18(1):20. doi: 10.1186/s12933-019-0828-y. Review.

4.

Increased β-Cell Workload Modulates Proinsulin-to-Insulin Ratio in Humans.

Mezza T, Ferraro PM, Sun VA, Moffa S, Cefalo CMA, Quero G, Cinti F, Sorice GP, Pontecorvi A, Folli F, Mari A, Alfieri S, Giaccari A.

Diabetes. 2018 Nov;67(11):2389-2396. doi: 10.2337/db18-0279. Epub 2018 Aug 21.

5.

Effect of Vitamin D Supplementation on Obesity-Induced Insulin Resistance: A Double-Blind, Randomized, Placebo-Controlled Trial.

Cefalo CMA, Conte C, Sorice GP, Moffa S, Sun VA, Cinti F, Salomone E, Muscogiuri G, Brocchi AAG, Pontecorvi A, Mezza T, Giaccari A.

Obesity (Silver Spring). 2018 Apr;26(4):651-657. doi: 10.1002/oby.22132. Epub 2018 Mar 4.

6.

Spotlight on ertugliflozin and its potential in the treatment of type 2 diabetes: evidence to date.

Cinti F, Moffa S, Impronta F, Cefalo CM, Sun VA, Sorice GP, Mezza T, Giaccari A.

Drug Des Devel Ther. 2017 Oct 3;11:2905-2919. doi: 10.2147/DDDT.S114932. eCollection 2017. Review.

7.

Insulin and the Future Treatment of Alzheimer's Disease.

Semprini R, Koch G, Belli L, Lorenzo FD, Ragonese M, Manenti G, Sorice GP, Martorana A.

CNS Neurol Disord Drug Targets. 2016;15(6):660-4. Review.

PMID:
27189471
8.

β-Cell Glucose Sensitivity Is Linked to Insulin/Glucagon Bihormonal Cells in Nondiabetic Humans.

Mezza T, Sorice GP, Conte C, Sun VA, Cefalo CM, Moffa S, Pontecorvi A, Mari A, Kulkarni RN, Giaccari A.

J Clin Endocrinol Metab. 2016 Feb;101(2):470-5. doi: 10.1210/jc.2015-2802. Epub 2015 Dec 9.

9.

Metabolic consequences of the occlusion of the main pancreatic duct with acrylic glue after pancreaticoduodenectomy.

Mezza T, Clemente G, Sorice GP, Conte C, De Rose AM, Sun VA, Cefalo CM, Pontecorvi A, Nuzzo G, Giaccari A.

Am J Surg. 2015 Oct;210(4):783-9. doi: 10.1016/j.amjsurg.2014.12.052. Epub 2015 Apr 30.

PMID:
26004536
10.

Peroxiredoxin 6, a novel player in the pathogenesis of diabetes.

Pacifici F, Arriga R, Sorice GP, Capuani B, Scioli MG, Pastore D, Donadel G, Bellia A, Caratelli S, Coppola A, Ferrelli F, Federici M, Sconocchia G, Tesauro M, Sbraccia P, Della-Morte D, Giaccari A, Orlandi A, Lauro D.

Diabetes. 2014 Oct;63(10):3210-20. doi: 10.2337/db14-0144. Epub 2014 Jun 19.

11.

HCC development is associated to peripheral insulin resistance in a mouse model of NASH.

De Minicis S, Agostinelli L, Rychlicki C, Sorice GP, Saccomanno S, Candelaresi C, Giaccari A, Trozzi L, Pierantonelli I, Mingarelli E, Marzioni M, Muscogiuri G, Gaggini M, Benedetti A, Gastaldelli A, Guido M, Svegliati-Baroni G.

PLoS One. 2014 May 22;9(5):e97136. doi: 10.1371/journal.pone.0097136. eCollection 2014.

12.

IL-21 is a major negative regulator of IRF4-dependent lipolysis affecting Tregs in adipose tissue and systemic insulin sensitivity.

Fabrizi M, Marchetti V, Mavilio M, Marino A, Casagrande V, Cavalera M, Moreno-Navarrete JM, Mezza T, Sorice GP, Fiorentino L, Menghini R, Lauro R, Monteleone G, Giaccari A, Fernandez Real JM, Federici M.

Diabetes. 2014 Jun;63(6):2086-96. doi: 10.2337/db13-0939. Epub 2014 Jan 15.

13.

Insulin resistance alters islet morphology in nondiabetic humans.

Mezza T, Muscogiuri G, Sorice GP, Clemente G, Hu J, Pontecorvi A, Holst JJ, Giaccari A, Kulkarni RN.

Diabetes. 2014 Mar;63(3):994-1007. doi: 10.2337/db13-1013. Epub 2013 Nov 11.

14.

Combined acute hyperglycemic and hyperinsulinemic clamp induced profibrotic and proinflammatory responses in the kidney.

Mariappan MM, DeSilva K, Sorice GP, Muscogiuri G, Jimenez F, Ahuja S, Barnes JL, Choudhury GG, Musi N, DeFronzo R, Kasinath BS.

Am J Physiol Cell Physiol. 2014 Feb 1;306(3):C202-11. doi: 10.1152/ajpcell.00144.2013. Epub 2013 Oct 9.

15.

High-normal TSH values in obesity: is it insulin resistance or adipose tissue's guilt?

Muscogiuri G, Sorice GP, Mezza T, Prioletta A, Lassandro AP, Pirronti T, Della Casa S, Pontecorvi A, Giaccari A.

Obesity (Silver Spring). 2013 Jan;21(1):101-6. doi: 10.1002/oby.20240.

16.

Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus.

Kiechl S, Wittmann J, Giaccari A, Knoflach M, Willeit P, Bozec A, Moschen AR, Muscogiuri G, Sorice GP, Kireva T, Summerer M, Wirtz S, Luther J, Mielenz D, Billmeier U, Egger G, Mayr A, Oberhollenzer F, Kronenberg F, Orthofer M, Penninger JM, Meigs JB, Bonora E, Tilg H, Willeit J, Schett G.

Nat Med. 2013 Mar;19(3):358-63. doi: 10.1038/nm.3084. Epub 2013 Feb 10.

PMID:
23396210
17.

Removal of duodenum elicits GLP-1 secretion.

Muscogiuri G, Mezza T, Prioletta A, Sorice GP, Clemente G, Sarno G, Nuzzo G, Pontecorvi A, Holst JJ, Giaccari A.

Diabetes Care. 2013 Jun;36(6):1641-6. doi: 10.2337/dc12-0811. Epub 2013 Feb 7.

18.

Vitamin D deficiency: a new risk factor for type 2 diabetes?.

Mezza T, Muscogiuri G, Sorice GP, Prioletta A, Salomone E, Pontecorvi A, Giaccari A.

Ann Nutr Metab. 2012;61(4):337-48. doi: 10.1159/000342771. Epub 2012 Dec 3. Review.

19.

Metabolic syndrome in transplant patients: an updating point of view.

Sorice GP, Di Pizio L, Sun VA, Schirò T, Muscogiuri G, Mezza T, Cefalo CM, Prioletta A, Pontecorvi A, Giaccari A.

Minerva Endocrinol. 2012 Sep;37(3):211-20. Review.

PMID:
22766888
20.

Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives.

Muscogiuri G, Sorice GP, Ajjan R, Mezza T, Pilz S, Prioletta A, Scragg R, Volpe SL, Witham MD, Giaccari A.

Nutr Metab Cardiovasc Dis. 2012 Feb;22(2):81-7. doi: 10.1016/j.numecd.2011.11.001. Epub 2012 Jan 21. Review.

PMID:
22265795
21.

In anorexia nervosa, even a small increase in abdominal fat is responsible for the appearance of insulin resistance.

Prioletta A, Muscogiuri G, Sorice GP, Lassandro AP, Mezza T, Policola C, Salomone E, Cipolla C, Della Casa S, Pontecorvi A, Giaccari A.

Clin Endocrinol (Oxf). 2011 Aug;75(2):202-6. doi: 10.1111/j.1365-2265.2011.04046.x.

PMID:
21521315
22.

Single-fiber conduction velocity test allows earlier detection of abnormalities in diabetes.

Padua L, Stålberg E, Caliandro P, Muscogiuri G, Pazzaglia C, Sorice GP, Granata G, Salomone E, Pontecorvi A, Giaccari A.

Muscle Nerve. 2011 May;43(5):652-6. doi: 10.1002/mus.21935.

PMID:
21484824
23.

Metabolic syndrome in transplant patients: an academic or a health burden?

Sorice GP, Muscogiuri G, Mezza T, Prioletta A, Giaccari A.

Transplant Proc. 2011 Jan-Feb;43(1):313-7. doi: 10.1016/j.transproceed.2010.09.099.

PMID:
21335212
24.

Will vitamin D reduce insulin resistance? Still a long way to go.

Muscogiuri G, Sorice GP, Prioletta A, Policola C, Della Casa S, Pontecorvi A, Giaccari A.

Am J Clin Nutr. 2011 Mar;93(3):672-3; author reply 673-4. doi: 10.3945/ajcn.110.009068. Epub 2011 Jan 5. No abstract available.

PMID:
21209228
25.

Medical therapy of aortic aneurysms: a pathophysiology-based approach.

Muscogiuri G, Sorice GP, Tripathy D, Chavez AO, Davalli A, Lange RA, Folli F.

Curr Vasc Pharmacol. 2011 Sep;9(5):572-84. Review.

PMID:
21143163
26.

The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship?

Muscogiuri G, Sorice GP, Prioletta A, Mezza T, Cipolla C, Salomone E, Giaccari A, Pontecorvi A, Della Casa S.

Clin Endocrinol (Oxf). 2011 Mar;74(3):300-5. doi: 10.1111/j.1365-2265.2010.03928.x.

PMID:
21070314
27.

Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes: comment to Kayaniyil et al.

Muscogiuri G, Sorice GP, Prioletta A, Policola C, Della Casa S, Pontecorvi A, Giaccari A.

Diabetes Care. 2010 Jul;33(7):e99; author reply e100. doi: 10.2337/dc10-0587. No abstract available.

PMID:
20587719
28.

25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity.

Muscogiuri G, Sorice GP, Prioletta A, Policola C, Della Casa S, Pontecorvi A, Giaccari A.

Obesity (Silver Spring). 2010 Oct;18(10):1906-10. doi: 10.1038/oby.2010.11. Epub 2010 Feb 11.

29.

A combination of PPAR-gamma agonists and HMG CoA reductase inhibitors (statins) as a new therapy for the conservative treatment of AAS (aortic aneurysm syndromes).

Sorice GP, Folli F.

Med Hypotheses. 2009 Oct;73(4):614-8. doi: 10.1016/j.mehy.2009.04.058. Epub 2009 Jul 4.

PMID:
19577852

Supplemental Content

Loading ...
Support Center